01 24MSD SUB MERCK
01 27326708
02 27326708*PED
03 88080580
04 69308204
05 29439901
06 49439902
01 10Y
02 14Blank
01 16Y
02 8Blank
01 22026-11-24
02 22027-05-24
03 82030-07-13
04 122030-10-21
Patent Expiration Date : 2030-10-21
ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9439902
Drug Substance Claim :
Drug Product Claim :
Application Number : 209806
Patent Use Code : U-2214
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-10-21
Patent Expiration Date : 2030-07-13
ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8080580
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209806
Patent Use Code : U-2214
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-07-13
Patent Expiration Date : 2030-07-13
US Patent Number : 8080580
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209803
Patent Use Code : U-2214
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-07-13
Patent Expiration Date : 2026-11-24
ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE
US Patent Number : 7326708
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209805
Patent Use Code : U-2214
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-11-24
Patent Expiration Date : 2030-07-13
ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE
US Patent Number : 8080580
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209805
Patent Use Code : U-2214
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-07-13
Patent Expiration Date : 2026-11-24
ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE
US Patent Number : 7326708
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209805
Patent Use Code : U-2214
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-11-24
Patent Expiration Date : 2030-10-21
ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9439902
Drug Substance Claim :
Drug Product Claim :
Application Number : 209806
Patent Use Code : U-2214
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-10-21
Patent Expiration Date : 2030-07-13
ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8080580
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209806
Patent Use Code : U-2214
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-07-13
Patent Expiration Date : 2030-07-13
US Patent Number : 8080580
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209803
Patent Use Code : U-2214
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-07-13
Patent Expiration Date : 2030-07-13
ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE
US Patent Number : 8080580
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209805
Patent Use Code : U-2214
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-07-13
LOOKING FOR A SUPPLIER?
